December 2, 2010
Scientists are hoping to use pioneering new technology to combat bowel cancer - a disease to which Ashkenazi Jews are disproportionately vulnerable.
While the risk of contracting it is one in 20 in the general population, it is up to one in 10 among Ashkenazis.
For three years, a group has been researching the genetic profile of the disease by studying Ashkenazim DNA samples. Now they believe they can advance their knowledge through a technique known as next-generation sequencing, which involves studying the actual cancer itself.